China reported a slight decline in new COVID-19 cases on Saturday as numerous cities battled outbreaks, and as restaurants and other businesses in Beijing shut after authorities urged people to stay home over the weekend.
Anti-abortion groups on Friday filed a lawsuit asking a court to overturn U.S. regulators' approval of the drug mifepristone for medication abortion, which could hobble access to medication abortion nationwide.
Canadian hospitals are straining to care for an influx of sick children, many with respiratory illnesses, in the midst of staffing constraints and as a shortage of children's over-the-counter medication sends more kids to hospital.
The divided U.S. Congress after the November midterm elections undermines pharmaceutical companies who want to weaken a new law that allows the government to negotiate drug prices, Republican strategists, policy experts and pharmaceutical executives say.
There are no approved vaccines and only one drug in the United States for respiratory syncytial virus (RSV), a common respiratory virus that usually causes mild, cold-like symptoms but can also lead to serious illness and hospitalization.
Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.
The U.S. Centers for Disease Control and Prevention estimated on Friday that Omicron subvariants BQ.1 and BQ.1.1 account for nearly half of the COVID-19 cases in the country for the week ending Nov. 19, compared with 39.5% in the previous week.
Berlin's zoo closed its doors without warning on Friday out of precaution after a case of avian flu was discovered in a wading bird that died earlier this week, it said in a statement.
Provention Bio Inc has priced its diabetes drug teplizumab at $13,850 a vial, it said on Friday, a day after receiving U.S. approval and far higher than some analysts' expectations.
A federal judge on Friday sentenced Theranos founder Elizabeth Holmes to 11 years and three months in prison for defrauding investors in her now-defunct blood-testing startup that was once valued at $9 billion.
